Back to MORGAN STANLEY MORGAN STANLEY

URGNURGN
Showing 8 of 9 quarters

Position history for MORGAN STANLEYMORGAN STANLEY's holdings in UROGEN PHARMA LTD

MORGAN STANLEY holds 2.6M shares of URGN (UROGEN PHARMA LTD), worth $94.8M as of 2026-Q2. The position was increased (+0.6% shares). URGN represents 0.0% of MORGAN STANLEY's portfolio.

Current Value

$94.8M

Current Shares

2.6M

Total Value Change

+$67.1M

Total Shares Change

+394,899

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
2.6M
+0.6%
$94.8M0.0%$36.80
30
2026-Q1
Decreased
2.6M
-0.1%
$46M0.0%$18.82
0
2025-Q4
Increased
2.6M
+1.4%
$60M0.0%$23.17
30
2025-Q3
Increased
2.5M
+2.0%
$50.4M0.0%$19.14
30
2025-Q2
Increased
2.5M
+189.0%
$34M0.0%$13.49
47
2025-Q1
Increased
857,727
+11.8%
$9.5M0.0%$11.20
31
2024-Q4
Decreased
767,300
-64.8%
$8.2M0.0%$10.52
0
2024-Q3
Increased
2.2M
+18.6%
$27.7M0.0%$12.90
34

Other major holders of URGN: RTW INVESTMENTS, LP, BlackRock, Inc., MENORA MIVTACHIM HOLDINGS LTD.

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used